Medical Condition News

RSS

Diabetic retinopathy: 5.3M U.S adults suffer

Despite major progress in diagnosis and treatment, diabetic retinopathy remains the major cause of blindness in adults under 60 in the U.S., said Thomas C. Lee, director, Retina Institute in The Vision Center at Childrens Hospital Los Angeles, associate professor of clinical ophthalmology at the Keck School of Medicine of the University of Southern California and attending physician at Doheny Eye Institute.

12 Feb 2010

"Goin' Bald for Bucks" program: RPCI CEO to shave head and mustache in honor of cancer patients

Dr. Donald L. Trump, President and CEO of Roswell Park Cancer Institute (RPCI), America's first cancer center, will have his head shaved by a Roswell Park cancer patient on March 3, 2010 to honor the Institute's 26,292 patients, and to encourage others to participate in the "Goin' Bald for Bucks" program.

12 Feb 2010

New research finds sensory cortex develops late in fragile X syndrome defect

Why do people with fragile X syndrome, a genetic defect that is the best-known cause of autism and inherited mental retardation, recoil from hugs and physical touch - even from their parents?

12 Feb 2010

Adult stem cell transplant therapy may help prevent amputations from PAD

Grant Medical Center recently completed the nation's first published study of a new procedure that may give hope to millions of patients facing lower limb amputations from peripheral arterial disease (PAD). PAD is a painful circulatory problem in the legs that affects 10 million Americans. If left untreated, it can lead to serious complications such as stroke, amputation and death.

12 Feb 2010

White rye flour bread leads to better insulin and blood sugar levels than wheat bread with rye bran

Wholegrain bread is good and good for you, as most people know. But it is not only the fiber-rich bran, the outer shell of the grain, that is healthful. On the contrary, research at the Lund University Faculty of Engineering shows that bread baked with white rye flour, which is flour made from the inner, white part of the rye kernel, leads to better insulin and blood sugar levels compared with wheat bread with rye bran. White rye flour thus leads to much better values than both regular wheat flour and rye bran. At the same time, much of the bread that is sold in stores today in most countries is in fact baked with wheat flour and bran from various grains.

12 Feb 2010

VR technology plays important role in treating patients with PTSD

Posttraumatic stress disorder (PTSD) threatens to overload healthcare and social support systems worldwide as the number of cases rises and existing treatments are not sufficiently effective.

12 Feb 2010

Histone modifications associated with pancreatic cancer development and progression

Specific chemical modifications to proteins called histones, which are found in the nucleus of cells and act as spools around which DNA is wound, can be used to predict prognosis and response to treatment in subsets patients with pancreatic cancer, a study by researchers at UCLA's Jonsson Comprehensive Cancer Center has found.

12 Feb 2010

Gold nanoparticles for cancer treatment

World Gold Council (WGC) has today published 'Gold for Good: Gold and nanotechnology in the age of innovation', a research paper detailing new scientific and technological innovations using gold. The report, which was produced in conjunction with Cientifica Ltd, the world's leading source of global business and investor intelligence about nanotechnologies, demonstrates how gold nanoparticles offer the potential to overcome many of the serious issues facing mankind over the coming decades.

12 Feb 2010

Data demonstrates the effectiveness of NeuroAiD on neuronal and brain injuries

The January issue of "Neuropharmacology", publishes the article entitled "Neuroprotective and Neuroproliferative Activities of NeuroAiD", reporting pharmacological data establishing NeuroAiD (MLC 601) protective effects on neuronal and brain injuries as well as its effectiveness in neurological functions recovery.

12 Feb 2010

Learning Lab of Brentwood to present free seminar on ADHD in Brentwood

The Learning Lab of Brentwood will present a free seminar, ADHD Kids: Getting Along Socially, on Thursday February 18 from 12:00-1:30 PM at the Maryland Farms YMCA in Brentwood.

12 Feb 2010

Anti-PC antibody linked to reduced risk of arteriosclerosis

The chances of suffering a stroke are linked to the presence of a certain type of antibody in the immune system, a new study from Karolinska Institutet shows. The researchers hope to be able to develop a vaccine that can mobilise the body's own defence against arteriosclerosis and stroke.

12 Feb 2010

Glycotex announces the expansion of patent portfolio in Advanced Wound Healing for GLYC-101

Glycotex, Inc. today announced the expansion of its patent portfolio in Advanced Wound Healing for its product candidate GLYC-101 currently in clinical phase 2 in the United States.

12 Feb 2010

Cal-EPA intents to add BPA to state's list of chemicals known to cause cancer

The California Environmental Protection Agency signaled intent to add bisphenol A (BPA) to the state's list of chemicals known to cause cancer or birth defects, adding to evidence the chemical should be banned from food and beverage containers.

12 Feb 2010

AHA survey: Heart disease and stroke patients fare poorly under current health care system

A new American Heart Association survey substantiates that the need for health care reform has not gone away. Many heart disease and stroke patients are faring poorly under the current health care system, with nearly two-thirds citing affordability as the top concern of those suffering from cardiovascular disease.

12 Feb 2010

Encouraging results from Circassia's ToleroMune ragweed allergy T-cell vaccine phase II clinical trial

Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that its ToleroMune(R) ragweed allergy T-cell vaccine achieved positive results in a recently completed phase II clinical trial. Ragweed allergy is particularly common in America, where it affects approximately 25% of the population. Circassia's latest clinical results follow two earlier successful phase II studies with the company's T-cell vaccine against cat allergy.

12 Feb 2010

Peregrine Pharmaceuticals' Cotara specifically targets solid tumors and anti-tumor activity

Peregrine Pharmaceuticals, Inc. (PPHM) today reported publication of data in the online edition of the journal Current Cancer Therapy Reviews that supports the clinical potential of the company's novel brain cancer agent Cotara® for the treatment of patients with glioblastoma multiforme (GBM), the deadliest form of brain cancer. Cotara specifically targets cells at the center of brain tumors, so its radioactive payload is able to kill cancer cells while leaving healthy tissue largely unaffected. Cotara is currently being tested in a Phase II clinical trial in recurrent GBM patients.

12 Feb 2010

IPF added to Social Security's "Compassionate Allowances" program

The Coalition for Pulmonary Fibrosis is praising Social Security Commissioner Michael Astrue's announcement this morning via press release that Idiopathic Pulmonary Fibrosis (IPF), also known as Pulmonary Fibrosis (PF), and a listing of 37 other diseases and life-threatening medical conditions are the latest additions to Social Security's "Compassionate Allowances" program.

12 Feb 2010

Center for Adolescent Bariatric Surgery performs 100th LAGB procedure

Few treatments are available to help obese adolescents who are unable to lose weight and are already suffering from obesity-related health problems. Laparoscopic adjustable gastric banding (LAGB), an option for adults in the United States since 2001, is showing promise for teens. The Center for Adolescent Bariatric Surgery, which opened at NewYork-Presbyterian Morgan Stanley Children's Hospital in 2006, recently performed its 100th LAGB procedure.

12 Feb 2010

Ethnic and racial minorities less likely to receive A1C diabetes test

Ethnic and racial minorities bear a disproportionate share of America's diabetes epidemic but are significantly less likely than whites to receive a commonly used test to monitor control of blood glucose, according to Washington State University researchers.

12 Feb 2010

Genzyme announces 2-year data from eliglustat tartrate Phase 2 trial for Gaucher disease

Genzyme Corporation announced today two-year follow-up data from patients enrolled in the phase 2 clinical trial for its investigational oral therapy for Gaucher disease type 1 known as eliglustat tartrate (formerly Genz-112638). Continued improvements were observed across all endpoints, including bone disease, at the two-year timepoint, compared with baseline. The two-year results were presented for the first time today at the Lysosomal Disease Network WORLD Symposium in Miami, Fla.

12 Feb 2010

Medical Condition News

Diabetic retinopathy: 5.3M U.S adults suffer

"Goin' Bald for Bucks" program: RPCI CEO to shave head and mustache in honor of cancer patients

New research finds sensory cortex develops late in fragile X syndrome defect

Adult stem cell transplant therapy may help prevent amputations from PAD

White rye flour bread leads to better insulin and blood sugar levels than wheat bread with rye bran

VR technology plays important role in treating patients with PTSD

Histone modifications associated with pancreatic cancer development and progression

Gold nanoparticles for cancer treatment

Data demonstrates the effectiveness of NeuroAiD on neuronal and brain injuries

Learning Lab of Brentwood to present free seminar on ADHD in Brentwood

Anti-PC antibody linked to reduced risk of arteriosclerosis

Glycotex announces the expansion of patent portfolio in Advanced Wound Healing for GLYC-101

Cal-EPA intents to add BPA to state's list of chemicals known to cause cancer

AHA survey: Heart disease and stroke patients fare poorly under current health care system

Encouraging results from Circassia's ToleroMune ragweed allergy T-cell vaccine phase II clinical trial

Peregrine Pharmaceuticals' Cotara specifically targets solid tumors and anti-tumor activity

IPF added to Social Security's "Compassionate Allowances" program

Center for Adolescent Bariatric Surgery performs 100th LAGB procedure

Ethnic and racial minorities less likely to receive A1C diabetes test

Genzyme announces 2-year data from eliglustat tartrate Phase 2 trial for Gaucher disease

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News